Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury
Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To establish a process by which critically ill infants with parenteral nutrition-associated
liver disease can receive a fish oil-based intravenous lipid emulsion (Omegaven®) for
compassionate use when no satisfactory alternative treatments are available.
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio